Phibro Animal Health Corp. Announces CFO Departure and New Directors
Ticker: PAHC · Form: 8-K · Filed: Nov 12, 2024 · CIK: 1069899
| Field | Detail |
|---|---|
| Company | Phibro Animal Health Corp (PAHC) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-change, cfo-departure
TL;DR
Phibro's CFO is out, interim CFO in, and two new directors join the board.
AI Summary
Phibro Animal Health Corporation announced on November 7, 2024, the departure of its Chief Financial Officer, J. Scott Henry, effective November 15, 2024. The company also appointed Deanne K. R. Smith as interim CFO. Additionally, Phibro announced the election of two new directors, Dr. H. Steven B. Smith and Dr. David L. Urban, to its Board of Directors, effective November 7, 2024.
Why It Matters
The departure of a CFO can signal financial strategy shifts or internal challenges, while new board members may bring fresh perspectives or influence future company direction.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding future financial strategy and governance.
Key Players & Entities
- Phibro Animal Health Corporation (company) — Registrant
- J. Scott Henry (person) — Departing Chief Financial Officer
- Deanne K. R. Smith (person) — Interim Chief Financial Officer
- Dr. H. Steven B. Smith (person) — Newly Elected Director
- Dr. David L. Urban (person) — Newly Elected Director
- November 7, 2024 (date) — Effective date of board changes and earliest event reported
- November 15, 2024 (date) — Effective date of CFO departure
FAQ
Who is replacing J. Scott Henry as CFO?
Deanne K. R. Smith has been appointed as the interim Chief Financial Officer.
When is J. Scott Henry's departure effective?
J. Scott Henry's departure as CFO is effective November 15, 2024.
Who are the new directors elected to the board?
Dr. H. Steven B. Smith and Dr. David L. Urban have been elected as new directors.
What is the effective date for the new board members?
The election of the new directors is effective November 7, 2024.
What is the company's primary business?
Phibro Animal Health Corporation is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Stats: 469 words · 2 min read · ~2 pages · Grade level 15 · Accepted 2024-11-12 16:15:24
Key Financial Figures
- $0.0001 — ch registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto
Filing Documents
- tm2428196d1_8k.htm (8-K) — 23KB
- 0001104659-24-116790.txt ( ) — 192KB
- pahc-20241107.xsd (EX-101.SCH) — 3KB
- pahc-20241107_lab.xml (EX-101.LAB) — 33KB
- pahc-20241107_pre.xml (EX-101.PRE) — 22KB
- tm2428196d1_8k_htm.xml (XML) — 4KB
02
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. (b) On November 7, 2024, Phibro Animal Health Corporation (the "Company") was notified by Rob Aukerman that he will be retiring from his position as President, North America Region of the Company effective December 31, 2024. Mr. Aukerman will continue with the Company until June 30, 2025 in an advisory capacity to ensure a smooth transition. Todd Armstrong, currently serving as Vice President of the US Ruminant Business since 2020, will be promoted to President, North American Region, effective January 1, 2025.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: November 12, 2024 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary